NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,116 | -80.2% | 28,738 | -80.9% | 0.00% | -77.8% |
| Q2 2023 | $86,369 | -18.2% | 150,154 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $105,543 | -81.0% | 150,154 | -39.0% | 0.01% | -84.6% |
| Q4 2022 | $556,236 | -44.3% | 246,122 | -21.1% | 0.06% | -16.7% |
| Q3 2022 | $999,000 | -9.5% | 312,107 | +7.4% | 0.08% | -14.3% |
| Q2 2022 | $1,104,000 | +102.2% | 290,489 | +186.9% | 0.09% | +97.8% |
| Q1 2022 | $546,000 | +23.0% | 101,237 | +208.3% | 0.05% | +17.9% |
| Q4 2021 | $444,000 | -34.5% | 32,835 | -13.0% | 0.04% | -51.9% |
| Q3 2021 | $678,000 | +289.7% | 37,759 | +273.3% | 0.08% | +200.0% |
| Q2 2021 | $174,000 | -56.7% | 10,114 | -57.2% | 0.03% | -78.6% |
| Q4 2020 | $402,000 | – | 23,644 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |